Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...
Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...
A large European cohort analysis evaluated pregnancy outcomes among women with sickle cell disease exposed to hydroxyurea, offering clinicians new evidence on maternal safety, fetal outcomes, and real-world...
Researchers investigated the impact of pre-transplant liver fibrosis on outcomes in patients with sickle cell disease undergoing hematopoietic stem cell transplantation.
A nationwide analysis reveals that patients with sickle cell disease (SCD) hospitalized for opioid overdose have comparable in-hospital mortality rates to patients without SCD, but exhibit better discharge...
A multicenter U.S. study published in Blood Advances found that digital cognitive behavioral therapy and a digital pain education program were equally effective in reducing pain interference among adults...
